Page last updated: 2024-09-02

1h-indene-2-carboxylic acid, 1-(1,3-benzodioxol-5-yl)-3-(2- (carboxymethoxy)-4-methoxyphenyl)-2,3-dihydro-5-propoxy-, (1s,2r,3s)- and Nerve Degeneration

1h-indene-2-carboxylic acid, 1-(1,3-benzodioxol-5-yl)-3-(2- (carboxymethoxy)-4-methoxyphenyl)-2,3-dihydro-5-propoxy-, (1s,2r,3s)- has been researched along with Nerve Degeneration in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Goto, K; Hayashi, K; Kasuya, Y; Uesugi, M1

Other Studies

1 other study(ies) available for 1h-indene-2-carboxylic acid, 1-(1,3-benzodioxol-5-yl)-3-(2- (carboxymethoxy)-4-methoxyphenyl)-2,3-dihydro-5-propoxy-, (1s,2r,3s)- and Nerve Degeneration

ArticleYear
SB209670, a potent endothelin receptor antagonist, prevents or delays axonal degeneration after spinal cord injury.
    Brain research, 1998, Mar-09, Volume: 786, Issue:1-2

    Topics: Animals; Axons; Endothelin Receptor Antagonists; Indans; Male; Microscopy, Electron; Nerve Degeneration; Rats; Rats, Wistar; Spinal Cord Injuries; Time Factors

1998